You are here

Takeda

AstraZeneca, Nycomed Antitrust Probe Ended by EU Regulators

Bloomberg

Thu, 03/1/12 - 12:24 pm

China Biotech Week in Review: Fosun Pharma Plans Large Hong Kong IPO

Seeking Alpha

Sun, 02/12/12 - 11:34 am

Fosun Pharmaceutical

Shanghai Pharmaceutical

Shanghai Biochip

Changchun BCHT Biotechnology

Nanjing Pharmaceutical

GSK, Takeda say nay to in-house diagnostics units

FiercePharma

Sat, 02/11/12 - 12:42 pm

Takeda Settles With SEC Over Insider Trading

Pharmalot

Thu, 02/9/12 - 12:00 pm

insider trading

Takeda’s Daxas Fails to Win U.K. Cost Agency’s Backing

Bloomberg

Wed, 01/25/12 - 09:29 am

FDA OKs subcutaneous use of Takeda cancer drug

Reuters

Tue, 01/24/12 - 10:44 am

Takeda Phamaceutical to Cut 2,800 Jobs in Europe, U.S. by End Fiscal 2015

Bloomberg

Wed, 01/18/12 - 10:04 am

Onyx Pharma CFO plugs cancer pipeline amid rumored sales process

Fierce Biotech

Fri, 01/13/12 - 09:29 am

ONYX Pharmaceuticals

Takeda Actos Cancer Suits Combined in Louisiana Court, U.S. Panel Rules

Bloomberg

Sat, 12/31/11 - 01:00 pm

Takeda To Buy Small-Molecule Drug Maker For Up To $310 Million

WSJ Online

Tue, 12/20/11 - 07:56 pm

small molecule drugs

US FDA panel gives positive opinion to Affymax's anaemia drug peginesatide

Pharmabiz

Sat, 12/10/11 - 01:23 pm

chronic kidney disease

Takeda unveils plans for global vaccine business

Pharma Times, UK

Tue, 12/6/11 - 09:25 am

Takeda May Face 10,000 U.S. Suits Over Actos Cancer Claims

Bloomberg

Thu, 12/1/11 - 10:40 am

Takeda submits new drug application in the U.S. for Type 2 Diabetes Continue reading on Examiner.com Takeda submits new drug application in the U.S. for Type 2 Diabetes

Wall Street Journal

Sat, 11/26/11 - 11:08 am

Affymax and Takeda Report Additional Analyses of Peginesatide Phase 3 Studies in Dialysis Patients at the American Society of Nephrology’s Kidney Week 2011

Yahoo/BusinessWire

Sat, 11/12/11 - 12:16 pm

chronic kidney disease

10 largest upcoming pharma patent losses in the US

Fierce Pharma

Tue, 10/25/11 - 11:54 am

Bristol-Myers Squibb

Teva Pharmaceuticals

Abbott Laboratories

Takeda starts Phase III trials of first-in-class diabetes drug

Pharma Times, UK

Wed, 10/19/11 - 12:02 pm

Takeda Eyes Nycomed Integration Before Another Deal

WSJ

Sat, 10/15/11 - 01:04 pm

5 promising pancreatic cancer drugs

Fierce Biotech

Thu, 10/13/11 - 01:23 pm

HyperAcute Pancreas

NewLink Genetics

Merrimack Pharmaceuticals

pancreatic cancer

China Biotech Week In Review: Sinovac Begins Foray Into Animal Health Vaccine

Seeking Alpha

Sun, 10/2/11 - 12:45 pm

Cardinal Health

Sanjiu Medical and Pharmaceutical

Guangdong Zhongsheng Pharma

Pages